The Latest Breaking News from TGA

While Australia was busy defending the Pharmaceutical Benefits Scheme against threats from the United States in recent weeks, another issue related to the supply and trade of medicines was flying under the radar.

Despite social media hype, there is little evidence that the therapies, marketed as pills, shots and IV infusions, have any effects on ageing

More than half a century after its release, Hollywood continues to pay its dues to 'Airport,' the grandaddy of the modern disaster movie.

The healthcare complaints watchdog says at least two unnamed Sydney practitioners, allegedly posing as accredited medical professionals, are under investigation

TGA approved new indication for semaglutide drug in December 2024, but allocation to PBS still to be decided

The federal government yesterday released its response to the Senate inquiry into issues related to menopause. The inquiry recommended the government examine options to make menopause hormone therapy (MHT, or sometimes called hormone replacement therapy) more affordable and accessible, and address drug shortages.

Changes are coming into effect from February 1 about how paracetamol is sold in Australia.

Australia recently became the first country to legalize both MDMA and psilocybin-assisted psychiatric therapy

Australia’s Therapeutic Goods Administration (TGA) recently issued a safety alert requiring extra warnings to be included with the asthma and hay fever drug montelukast.

TikTok and Instagram influencers have been peddling the “Barbie drug” to help you tan.

A multi-million dollar business has developed in Australia to meet the demand for medicinal cannabis. Australians spent more than A$400 million on it in the first half of 2024 alone.